Tumor News and Research

RSS

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Merck KGaA, Darmstadt, Germany, and Pfizer Inc. today announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved BAVENCIO (avelumab, genetically recombinant Injection 200mg/mL for intravenous use) as the first and only treatment indicated for curatively unresectable Merkel cell carcinoma (MCC), a rare and aggressive cancer, in Japan.

27 Sep 2017

Notre Dame's HCRI publishes two papers involving ovarian cancer research

Two papers involving ovarian cancer research at the University of Notre Dame's Harper Cancer Research Institute, one featuring new research and the other a review article, were published as cover stories in their respective journals.

27 Sep 2017

Huddersfield cancer scientists aim to develop new treatments for young people

CANCER researchers at the University of Huddersfield aim to develop new treatments specifically for young people and they will be aided in their quest by financial support from a locally-based charity.

27 Sep 2017

Drug combination produces synergistic effect against growth of triple-negative breast cancer

In the hunt for novel treatments against an aggressive form of breast cancer, researchers combined a new protein inhibitor with a chemotherapy drug to create a powerful combination that resulted in cancer cell death.

26 Sep 2017

New approaches to treat aggressive NUT midline carcinoma

Precision medicine, which custom-tailors therapies to the needs of individual patients, is becoming more and more important in cancer therapy. Today, molecular-biological diagnostics can precisely identify alterations in tumor cells.

26 Sep 2017

Existing drugs may be able to improve therapy for chronic myeloid leukemia, mice study shows

Two drugs, already approved for safe use in people, may be able to improve therapy for chronic myeloid leukemia (CML), a blood cancer that affects myeloid cells, according to results from a University of Iowa study in mice.

26 Sep 2017

Pediatric researchers discover gene variants related to aggressive form of neuroblastoma

Pediatric researchers investigating the childhood cancer neuroblastoma have identified common gene variants that raise the risk of an aggressive form of that disease. The discovery may assist doctors in better diagnosing subtypes of neuroblastoma.

25 Sep 2017

Probiotic bacteria can change intestinal flora of patients with colon cancer, study finds

Living lactic acid bacteria, probiotics, can change the intestinal flora of patients with cancer of the colon. These are the findings of a study published in the journal BMJ Open Gastroenterology.

25 Sep 2017

New MRI contrast agent differentiates between aggressive and slow-growing breast cancers

A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between aggressive and slow-growing types.

25 Sep 2017

New gel patch could speed up healing and minimize formation of scars

Scientists from Nanyang Technological University, Singapore have developed a new gel patch prototype that could speed up the healing of a skin wound while minimizing the formation of scars. The team unveiled the patch today as a proof-of-concept.

25 Sep 2017

Targeting mutant p53 specific binding protein could lead to new therapeutic strategies for cancer patients

Research by Rutgers Cancer Institute of New Jersey investigators shows the targeting of a binding protein of mutant p53 known as Rac1 could lead to new therapeutic strategies for patients whose cancer carries mutations in the p53 gene.

22 Sep 2017

NCI selects UTSW cancer researcher to receive Outstanding Investigator Award

The National Cancer Institute has selected UT Southwestern Medical Center cancer researcher Dr. Ralph DeBerardinis to receive its prestigious Outstanding Investigator Award.

22 Sep 2017

Novel assay shows potential to detect circulating cancer biomarkers in blood samples

Future Science Group today announced the publication of an article in Future Science OA presenting early data from a novel assay for the non-invasive detection of PD-L1 and other biomarkers in patient blood samples.

22 Sep 2017

Researchers discover mechanism of drug resistance for ovarian and breast cancer cells

Researchers from the People's Friendship University of Russia have studied the mechanism of drug resistance for ovarian and breast cancer cells.

22 Sep 2017

Alternative splicing may also trigger cancer, study shows

Cancer, which is one of the leading causes of death worldwide, arises from the disruption of essential mechanisms of the normal cell life cycle, such as replication control, DNA repair and cell death.

22 Sep 2017

Diet and exercise have potential to improve chemotherapy effectiveness in pediatric cancer patients

Diet and exercise may improve treatment outcomes in pediatric cancer patients, according to a study at The University of Texas MD Anderson Children's Cancer Hospital.

21 Sep 2017

'Labyrinth' chip may be new way to monitor cancer patients in clinical trials

Inspired by the Labyrinth of Greek mythology, a new chip etched with fluid channels sends blood samples through a hydrodynamic maze to separate out rare circulating cancer cells into a relatively clean stream for analysis. It is already in use in a breast cancer clinical trial.

21 Sep 2017

Researchers identify molecular pathway that causes immune cells to promote cancer

Investigators at the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles have identified new findings about an immune cell - called a tumor-associated macrophage - that promotes cancer instead of fighting it.

21 Sep 2017

Indiana University awarded $4 million NSF grant to advance nanoscale medical devices

Only a year after establishing the intelligent systems engineering program in the Indiana University School of Informatics, Computing and Engineering, the university has been awarded a five-year, $4 million grant from the National Science Foundation to advance nanoscale devices to improve human health, including fighting cancer.

21 Sep 2017

Forgotten strands of DNA induce 'big bang' of immune cell development

Intricate human physiological features such as the immune system require exquisite formation and timing to develop properly. Genetic elements must be activated at just the right moment, across vast distances of genomic space.

21 Sep 2017

Tumor News and Research

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Notre Dame's HCRI publishes two papers involving ovarian cancer research

Huddersfield cancer scientists aim to develop new treatments for young people

Drug combination produces synergistic effect against growth of triple-negative breast cancer

New approaches to treat aggressive NUT midline carcinoma

Existing drugs may be able to improve therapy for chronic myeloid leukemia, mice study shows

Pediatric researchers discover gene variants related to aggressive form of neuroblastoma

Probiotic bacteria can change intestinal flora of patients with colon cancer, study finds

New MRI contrast agent differentiates between aggressive and slow-growing breast cancers

New gel patch could speed up healing and minimize formation of scars

Targeting mutant p53 specific binding protein could lead to new therapeutic strategies for cancer patients

NCI selects UTSW cancer researcher to receive Outstanding Investigator Award

Novel assay shows potential to detect circulating cancer biomarkers in blood samples

Researchers discover mechanism of drug resistance for ovarian and breast cancer cells

Alternative splicing may also trigger cancer, study shows

Diet and exercise have potential to improve chemotherapy effectiveness in pediatric cancer patients

'Labyrinth' chip may be new way to monitor cancer patients in clinical trials

Researchers identify molecular pathway that causes immune cells to promote cancer

Indiana University awarded $4 million NSF grant to advance nanoscale medical devices

Forgotten strands of DNA induce 'big bang' of immune cell development

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News